Numan Raises $20M in Debt; Closes $60.1M Series B Round

Numan, a UK-based digital platform for men’s health, raised $20M in debt funding from Kreos Capital and closed a $60.1M Series B funding round.

The round was led by White Star Capital, with participation from Novator, VNV Global, and Anthemis Exponential.

The new funding coincides with launch of blood testing proposition in the UK, as Numan looks to double headcount in 2022. The capital will be used to accelerate growth and consolidate growth as a consumer health brand for men in Europe, having grown revenues by almost 3x YoY. The company also plans to use the funding to launch new therapeutic areas in men’s health and expand internationally.

Led by Sokratis Papafloratos, CEO & founder, Numan provides a digital health clinic for men that offers direct-to-consumer health products and pharmaceuticals. The subscription service for healthcare treatments enables members to receive medication and other products to home rather than having a pharmacy trip. All patients have ongoing access to a team of clinicians who are on hand to help and inform them to make the best decisions for their health.

Numan is also regulated by the Care Quality Commission as a registered healthcare provider.